Form D · Biotechnology
Xilis, Inc.
Durham, NC · CIK 0001796056
Offering snapshot reported Apr 25, 2025 · SEC filing
- Reported sold
- $19.4M Offering amount: $19.4M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2025 | Initial | $19,405,205 | No comparison | 9 | SEC filing |
| Jul 14, 2022 | Initial | $16,514,618 | No comparison | 14 | SEC filing |
| Jul 9, 2021 | Initial | $70,000,006 | No comparison | Not reported | SEC filing |
| May 21, 2020 | Amendment | $4,849,998 | $1,849,999vs Dec 6, 2019 | 8 | SEC filing |
| Dec 6, 2019 | Initial | $2,999,999 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-544519
Includes $5,500,353.17 in convertible debt to one investor.
Source: Form D, filed Apr 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Halawa Alaa | Director, Executive |
| Wesley Chan | Director, Executive |
| John De Koning | Director |
| Alaa Halawa | Director |
| David Hsu | Director, Executive |
| Xiling Shen | Director, Executive |
| David Shiaowen | Director |
| William Roy Smythe | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
31 Alexandria Way
Durham, NC, 27713
Durham, NC, 27713